Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech layoffs
Biotech
Kolon TissueGene shrinks workforce after pivotal trial miss
Following a ph. 3 knee failure that its CEO acknowledged caused “great disappointment and concern,” TissueGene is laying off 37 Maryland employees.
Darren Incorvaia
Aug 18, 2026 4:00pm
Fierce Biotech Layoff Tracker 2026: Kolon, Sanofi & more
Aug 18, 2026 9:40am
Merck KGaA makes further cuts to US research team
Aug 17, 2026 1:23pm
Ensoma sheds more staff, pauses preclinical programs
Aug 7, 2026 11:16am
Amgen sheds around 40 staffers as struggles mount
Jul 24, 2026 4:45pm
Merck KGaA in-office requirement could lead to 70 US layoffs
Jul 13, 2026 2:32pm